Hcw Biologics Inc (HCWB) Stock Price, Quote & News

Company Profile

HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States. The company's lead products include HCW9218, a clinical-stage bifunctional molecule, which has completed Phase 1 to treat chemotherapy-refractory solid tumor cancers and Phase 1b/2 to treat pancreatic cancer; and HCW9302, injectable and interleukin 2 (IL-2) fusion protein complex, which is i...

Industry: Biotechnology

Sector: Healthcare

Phone: 954 842 2024

Fax: 954 842 2037

Website: www.hcwbiologics.com

Address:

2929 North Commerce Parkway, Miramar, United States

topstockalerts May. 16 at 10:58 AM

Friday’s Top Gainers $HCWB $PIII $MRNO $AUUD $SLE

0 · Reply

Terrytyler May. 16 at 8:40 AM

$HCWB normally i saw several stock if they drop more than -10% never saw move up for while..........for me its done wasting time to chasing

0 · Reply

Terrytyler May. 16 at 8:33 AM

$HCWB neither $2 yet $5 is too far way............I don't think so but in stock gambling any thing possible...........

0 · Reply

TALENT_ON_LOAN_FROM_GOD May. 16 at 6:56 AM

$QUCY CHECKING IN…. WHAT A WEEK CHEERS MONEYMADE $HCWB EARLY ~ Load $QUCY RIDING FREE SHARES $BZFD NOT YET DISCOVERED ~Load $TDIC DID NOT DISAPPOINT~TRADE ONLY

0 · Reply

TALENT_ON_LOAN_FROM_GOD May. 16 at 6:49 AM

$HCWB EASILY

0 · Reply

ThatEscalatedQuickly May. 16 at 3:20 AM

$YMAT $SNAL $TDIC $HKIT $HCWB Fridays P&L, made some good momentum swing trades, some not, overextended on two. Being spread out over 5 trades helped. Hope to post a better Monday 💰😎📈 God speed gents & ladies 🙏🏽 Today's P&L -2.07% Red Day 5/15

0 · Reply

ThatEscalatedQuickly May. 16 at 2:30 AM

$QUCY $YMAT $SNAL $HCWB $TDIC [*feel free to share] For small accounts under 25K [>I use Kraken Pro and WeBull] Here are my 7 rules; [*plus DD, TA, OS, Vol., etc.] Whenever Ive lost on a trade, Ive Broken One of My Rules [*today included] 1. Don't trade Intraday, without an exit trade available 🫣 2. Don't Chase halt ups, buy Only on Consolidation 🙄 3. Dont buy lower highs, lower lows 📩 4. Don't trade more than 10% of available powder 💰 on any given trade 5. Only Buy Swing trades after hours, close to 1700 PST or TA [*let things settle in] 😔 momentum trade FREE 6. Dont Chase a Losing trade. Set a SL, live to fight another day 💪🏽 7. If you feel emotional, Take a Break! 😎

1 · Reply

TravisBking87 May. 16 at 2:27 AM

$HCWB Traded this 3 times made good thanks to @jacksparo group

0 · Reply

MACnTEEZ May. 16 at 1:34 AM

$HCWB donny boy, even if it did drop to .80 thats nothing, beautiful dip buying opportunity!! Will get eaten the fuck up!! Lmao , dont flex to hard with your 1.17 short average lmao

1 · Reply

P3acemaker May. 16 at 12:50 AM

$ARAY false, look what $HCWB did yesterday - started to sell off and then BOOM 💥 A 10 year research partnership with a giant university was just inked, this company ain’t going nowhere

0 · Reply

Why Is Penny Stock HCW Biologics (HCWB) Up Today?

May 14, 2026, 4:25 PM EDT - 1 day ago

HCW Biologics Reports First Quarter 2026 Business Highlights and Financial Results

2026-05-14T14:02:07.000Z - 1 day ago

HCW Biologics discovers HCW11-040 prevents bronchopulmonary dysplasia

May 14, 2026, 7:30 AM EDT - 1 day ago

HCW Biologics Discovers that HCW11-040 Prevents Bronchopulmonary Dysplasia (BPD) During IND-Enabling Studies

Apr 30, 2026, 4:20 PM EDT - 15 days ago

HCW Biologics Announces Adjournment of Special Meeting of Stockholders Due to Lack of Quorum

2026-04-27T13:34:49.000Z - 18 days ago

HCW Biologics to file IND for HCW11-018b in first half of 2027

Apr 27, 2026, 7:30 AM EDT - 18 days ago

HCW Biologics Delivers a Major Update for its T-Cell Engager Program Revealing Mechanism of Action and Validating Tissue Factor as Target for Treatment of Solid Tumors

Mar 31, 2026, 5:05 PM EDT - 6 weeks ago

HCW Biologics Reports Fourth Quarter 2025 and Fiscal Year 2025 Business Highlights and Financial Results

2026-03-17T12:00:45.000Z - 2 months ago

HCW Biologics closes exclusive worldwide license for HCW11-006

Mar 17, 2026, 7:50 AM EDT - 2 months ago

HCW Biologics Closes Exclusive Worldwide License for HCW11-006 – A High Potential Fusion Immunotherapeutic

2026-03-16T12:16:39.000Z - 2 months ago

HCW Biologics announces positive research results for CAR-T cell therapy

Mar 16, 2026, 8:00 AM EDT - 2 months ago

HCW Biologics Announces Positive Research Results for CAR-T Cell Therapy Manufactured Utilizing Its Commercial-Ready Proprietary Compound, HCW9206, Published in Science Advances

2026-03-02T13:38:50.000Z - 2 months ago

HCW Biologics regains compliance with continued listing rules for Nasdaq

Mar 2, 2026, 8:00 AM EST - 2 months ago

HCW Biologics Regains Compliance with All Continued Listing Rules for Nasdaq Per Nasdaq Determination Letter

Feb 17, 2026, 9:50 PM EST - 3 months ago

HCW Biologics Announces Pricing of $1.5 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules

2026-02-13T13:36:05.000Z - 3 months ago

HCW Biologics, WY Biotech close first round of financing for joint venture

Feb 13, 2026, 8:30 AM EST - 3 months ago

HCW Biologics and WY Biotech Announce Closing of First Round of Financing For Newly Formed Joint Venture Trimmune

2026-02-11T22:30:18.000Z - 3 months ago

HCW Biologics files to sell 9.52M shares of common stock, warrants

2026-01-09T21:55:16.000Z - 4 months ago

HCW Biologics files to sell 3.4M shares of common stock for holders

2025-11-19T13:41:14.000Z - 6 months ago

HCW Biologics enters $4M warrant inducement

2025-11-18T12:30:10.000Z - 6 months ago

HCW Biologics announces initiation of FIH trial of HW9302

Nov 18, 2025, 7:25 AM EST - 6 months ago

HCW Biologics Announces Initiation of First-In-Human Clinical Trial to Evaluate HCW9302 in an Autoimmune Disease

Nov 14, 2025, 4:44 PM EST - 6 months ago

HCW Biologics Reports Third Quarter 2025 Business Highlights and Financial Results

2025-11-10T12:50:51.000Z - 6 months ago

HCW Biologics announces latest update for tetra-valent ICI Program

2025-11-07T12:12:29.000Z - 6 months ago

HCW Biologics announces data presented for TCE Program based on TRBC platform

Nov 7, 2025, 7:00 AM EST - 6 months ago

HCW Biologics Presents Preclinical Data for TRBC-Based T-Cell Engager Program at the Society for Immunotherapy of Cancer's (SITC) 40th Annual Meeting

2025-10-22T13:16:22.000Z - 7 months ago

HCW Biologics participates in virtual investor ‘What This Means’ segment

Oct 16, 2025, 9:25 AM EDT - 7 months ago

HCW Biologics to Participate in the 2025 Maxim Growth Summit

Sep 30, 2025, 8:45 AM EDT - 8 months ago

HCW Biologics Inc. (NASDAQ: HCWB) Participates in Virtual Investor “What This Means” Segment About its Proprietary T-Cell Engager Program

2025-09-18T13:25:28.000Z - 8 months ago

HCW Biologics congratulates Wugen on equity financing

Sep 18, 2025, 9:15 AM EDT - 8 months ago

HCW Biologics, a Shareholder of Wugen, Congratulates Wugen on Its Recent Successful Equity Financing

Sep 16, 2025, 8:00 AM EDT - 8 months ago

HCW Biologics Designates One of Its Proprietary TRBC-Pembrolizumab-Based Immune Checkpoint Inhibitors as its Franchise Immunotherapeutic for Internal Clinical Development

2025-09-09T12:05:14.000Z - 8 months ago

HCW Biologics announces results from second-gen T-cell engager programs

2025-08-26T01:09:00.000Z - 9 months ago

HCW Biologics Stock Rockets 55% on Cancer Treatment Data

Aug 25, 2025, 8:00 AM EDT - 9 months ago

HCW Biologics to Showcase its Novel Second-Generation Immune Checkpoint Inhibitor Identified as a Potential Gateway to a Multi-Billion Dollar Market

Aug 18, 2025, 2:44 PM EDT - 9 months ago

HCW Biologics Reports Second Quarter 2025 Business Highlights and Financial Results

Jun 27, 2025, 7:45 AM EDT - 11 months ago

HCW Biologics to Showcase Important Updates on IND-Enabling Studies and Preclinical Success of Its Novel Multi-Specific T-Cell Engagers Against Solid Tumors

Jun 26, 2025, 7:55 AM EDT - 11 months ago

HCW Biologics Regains Compliance with Nasdaq Capital Market Requirements

Jun 4, 2025, 8:20 AM EDT - 1 year ago

HCW Biologics Completes Deliverable and Solidifies License Agreement with WY Biotech

May 15, 2025, 6:14 PM EDT - 1 year ago

HCW Biologics Reports First Quarter 2025 Business Highlights and Financial Results

May 13, 2025, 8:01 PM EDT - 1 year ago

HCW Biologics Announces Pricing of $5.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules

May 13, 2025, 8:30 AM EDT - 1 year ago

HCW Biologics Announces Positive Results of Studies of Proprietary Compound, HCW9206 and Availability for Commercialization

Apr 1, 2025, 4:35 PM EDT - 1 year ago

HCW Biologics Announces 1-for-40 Reverse Stock Split

Mar 28, 2025, 3:30 PM EDT - 1 year ago

HCW Biologics Reports Fourth Quarter and Fiscal Year 2024 Business Highlights and Financial Results

Mar 6, 2025, 6:55 AM EST - 1 year ago

HCW Biologics Granted Extension by the Nasdaq Hearings Panel to Regain Compliance with Continued Listing Requirements

Feb 3, 2025, 7:15 AM EST - 1 year ago

HCW Biologics Granted FDA Clearance to Evaluate One of the Company's Lead Product Candidates in a First-In-Human Phase 1 Clinical Trial

Jan 15, 2025, 7:00 AM EST - 1 year ago

HCW Biologics' Founder and CEO to Address Opportunities and Challenges in Biomanufacturing for Cell and Gene Therapies During J.P. Morgan Week in San Francisco on January 15, 2025

Dec 23, 2024, 8:10 AM EST - 1 year ago

HCW Biologics Inc. Received NASDAQ Staff Determination Letter

Nov 18, 2024, 9:27 PM EST - 1 year ago

HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules

Nov 18, 2024, 7:00 AM EST - 1 year ago

HCW Biologics and WY Biotech Announce License Agreement for Immunotherapeutic Product Candidate

Nov 14, 2024, 4:40 PM EST - 1 year ago

HCW Biologics Reports Third Quarter 2024 Financial Results and Business Highlights

Aug 23, 2024, 4:30 PM EDT - 1 year ago

HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights - Correction

Aug 14, 2024, 4:35 PM EDT - 1 year ago

HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights

May 15, 2024, 4:39 PM EDT - 2 years ago

HCW Biologics Reports First Quarter 2024 Financial Results and Business Highlights

Apr 1, 2024, 4:10 PM EDT - 2 years ago

HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business Highlights

Nov 14, 2023, 7:00 AM EST - 2 years ago

HCW Biologics Reports Third Quarter 2023 Financial Results And Recent Business Highlights

Nov 8, 2023, 7:30 AM EST - 2 years ago

Investigator Sponsor of HCW Biologics' Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual Meeting

Nov 1, 2023, 7:30 AM EDT - 2 years ago

Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation Human Data Readout for Phase 1 Study to Evaluate HCW9218 in Solid Tumors at SITC 38th Annual Meeting

Sep 6, 2023, 7:30 AM EDT - 2 years ago

HCW Biologics Participating at H.C. Wainwright 25th Annual Global Investment Conference in New York on September 11 – 13, 2023

Aug 11, 2023, 7:00 AM EDT - 3 years ago

HCW Biologics Reports Second Quarter 2023 Financial Results and Recent Business Highlights

Jun 14, 2023, 7:30 AM EDT - 3 years ago

HCW Biologics is Granted Third Fundamental Patent: U.S. Patent for Methods of Treating Age-Related Disorders

May 9, 2023, 7:15 AM EDT - 3 years ago

HCW Biologics Reports First Quarter 2023 Financial Results And Recent Business Highlights

Apr 27, 2023, 7:40 AM EDT - 3 years ago

HCW Biologics Secures $26.25 Million Non-Dilutive Financing With Asset-Backed Development Loan

Apr 13, 2023, 7:15 AM EDT - 3 years ago

HCW Biologics Poster Presentation at AACR Annual Meeting 2023

Apr 3, 2023, 8:13 AM EDT - 3 years ago

A Novel Immunotherapeutic Approach to Treating Aging-Associated Diseases

Mar 28, 2023, 4:25 PM EDT - 3 years ago

HCW Biologics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Business Highlights

Dec 8, 2022, 7:55 AM EST - 3 years ago

HCW Biologics Enters CRADA with National Cancer Institute

topstockalerts May. 16 at 10:58 AM

Friday’s Top Gainers $HCWB $PIII $MRNO $AUUD $SLE

0 · Reply

Terrytyler May. 16 at 8:40 AM

$HCWB normally i saw several stock if they drop more than -10% never saw move up for while..........for me its done wasting time to chasing

0 · Reply

Terrytyler May. 16 at 8:33 AM

$HCWB neither $2 yet $5 is too far way............I don't think so but in stock gambling any thing possible...........

0 · Reply

TALENT_ON_LOAN_FROM_GOD May. 16 at 6:56 AM

$QUCY CHECKING IN…. WHAT A WEEK CHEERS MONEYMADE $HCWB EARLY ~ Load $QUCY RIDING FREE SHARES $BZFD NOT YET DISCOVERED ~Load $TDIC DID NOT DISAPPOINT~TRADE ONLY

0 · Reply

TALENT_ON_LOAN_FROM_GOD May. 16 at 6:49 AM

$HCWB EASILY

0 · Reply

ThatEscalatedQuickly May. 16 at 3:20 AM

0 · Reply

ThatEscalatedQuickly May. 16 at 2:30 AM

1 · Reply

TravisBking87 May. 16 at 2:27 AM

$HCWB Traded this 3 times made good thanks to @jacksparo group

0 · Reply

MACnTEEZ May. 16 at 1:34 AM

$HCWB donny boy, even if it did drop to .80 thats nothing, beautiful dip buying opportunity!! Will get eaten the fuck up!! Lmao , dont flex to hard with your 1.17 short average lmao

1 · Reply

P3acemaker May. 16 at 12:50 AM

$ARAY false, look what $HCWB did yesterday - started to sell off and then BOOM 💥 A 10 year research partnership with a giant university was just inked, this company ain’t going nowhere

0 · Reply

topstockalerts May. 16 at 12:30 AM

$HCWB whoever wanted out appears to be out.

0 · Reply

Ripafterthedip May. 16 at 12:25 AM

$HCWB $5+ next?

0 · Reply

ThatEscalatedQuickly May. 16 at 12:22 AM

$FCUV in at .84 *Swing* ~ 600K float Micro cap Could see a reversal next week 📈💰😎 $QUCY in at 3.26.*swing* Looking for continuation 📈💰😎 Holding $SNAL $YMAT $HCWB See 👀 you Monday ... Time to connect with nature 🌳

0 · Reply

CallmeNostradamus May. 16 at 12:01 AM

$HCWB round 2 Monday cya then

0 · Reply

Parobolicbatman May. 15 at 11:59 PM

$HCWB look how well it held gains, very impressive

0 · Reply

ThatEscalatedQuickly May. 15 at 11:47 PM

$QUCY I'll take swing @3.26 Higher highs, Higher lows Market has been red after-hours, also a litany of pump & dumps after "bullish" earnings for several AH movers Don't see anything more I like Im choosing $QUCY 💰📈😎 Still holding $YMAT $HCWB $SNAL

0 · Reply

Dumbull77 May. 15 at 11:46 PM

$HCWB Out there, green and a good percentage up but still a bit disappointed. It does look like it'll be good Monday for HCWB to me so far though.

1 · Reply

Mr_Stochastic May. 15 at 11:42 PM

$HCWB $TDIC $AUUD $MRNO $EDBL

0 · Reply

TeamBullish May. 15 at 11:40 PM

No doubt in my mind we’ll be successful next week if we attack the same way we did this week. That said, level out your expectations. Momentum comes in cycles. When the opportunity is there, we attack it aggressively. When it’s not, we protect capital and stay disciplined. Do not let a hot market make you forget the fundamentals that got us paid in the first place. $AEHL $RXT $TDIC $QUCY $HCWB

2 · Reply

Bullishbrickie May. 15 at 11:21 PM

$HCWB every time I come on this chat you’re just spamming the same stuff🤣🤣

2 · Reply

Donniechen12345 May. 15 at 11:18 PM

$HCWB Ofcourse it will slowly drop to .80 in 2-3 days ,, they dont want to scare all the longs to sell right away, they will slowly drop it slowly and painfully so the longs wont sell right away and will sell at a much larger steeper loss .70-80 cents … thats brutal . ouch!!!

1 · Reply

V2IcedPriate May. 15 at 11:13 PM

$HCWB lets goo

0 · Reply

Market Cap	2.27M
Revenue (ttm)	50,000.00
Net Income (ttm)	-7.96M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-15,920.00%
Debt to Equity Ratio	2.47

Volume	394,354,313
Avg Vol	19,566,119
Day's Range	N/A - N/A
Shares Out	6.73M
Stochastic %K	82%
Beta	1.13
Analysts	Strong Sell
Price Target	$2.00